GALECTIN THERAPEUTICS INC. Equity Method Investment, Ownership Percentage
GALECTIN THERAPEUTICS INC. (GALT) had Equity Method Investment, Ownership Percentage of 50.00% as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Notes
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2014-11-10
- 2014-09-30: Equity Method Investment, Ownership Percentage 50.00%.
- 2014-06-30: Equity Method Investment, Ownership Percentage 50.00%.
- 2014-03-31: Equity Method Investment, Ownership Percentage 50.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2014-09-30 | 50.00% 10-Q · filed 2014-11-10 |
| 2014-06-30 | 50.00% 10-Q · filed 2014-08-07 |
| 2014-03-31 | 50.00% 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |